As of Wednesday close, Ginkgo Bioworks Holdings Inc.’s (NYSE:DNA) stock was down -$0.02, moving down -1.00 percent to $1.98. The average number of shares traded per day over the past five days has been 33,438,781 shares. 1 time new highs have been achieved over the past 5 days, with a -$0.3400 fall in that time frame. In the last twenty days, the average volume was 26,495,980, while in the previous 50 days, it was 26,359,459.
Since last month, DNA stock retreated -28.26%. Shares of the company fell to $1.9400 on 11/22/22, the lowest level in the past month. A 52-week high of $13.09 was reached on 01/03/22 after having rallying from a 52-week low of $1.94. Since the beginning of this year, DNA’s stock price has dropped by -76.17% or -$6.3300, and marked a new high 1 time. However, the stock has declined by -84.87% since its 52-week high.
China Can't Stop US$0.25 Stock from Mining Ultra-Rare Metal
Here's one little-known company — trading undiscovered below 25-cents per share — that's advancing one of the largest and highest quality REE deposits in all of North America... and the Chinese can't do a damn thing about it! It's early stage... and that's excellent news for individual investors like you who have the foresight to act decisively on an emerging megatrend that's already being measured in the Tens of $Billions.
Simply click here and the name & trading symbol are yours.
DNA stock investors should be aware that Ginkgo Bioworks Holdings Inc. (DNA) stock had its last reported insider trading activity 4 days ago on Nov 21. Kelly Jason R, the of the company, disposed of 103,765 shares for $2.10 on Nov 21. It resulted in a $217,906 divestment by the insider. Canton Barry sold 103,765 shares at an average price of $2.10 on Nov 21. The insider now owns 20,519,904 shares following the transaction. On Nov 21, 10% Owner Canton Barry sold 103,764 shares at $2.10 apiece. The transaction was valued at $217,904.
In the three months ended September 29, Ginkgo Bioworks Holdings Inc.’s quick ratio stood at 11.70, while its current ratio was 11.70, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending September 29 was 0.04, and the total debt-to-equity ratio was 0.04. On the profitability front, the trailing twelve-month gross margin is 54.40% percent. Based on annual data, DNA earned $184.15 million in gross profit and brought in $313.84 million in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was -119.60%. Return on equity (ROE) for the past 12 months was -233.10%.
According to the earnings report, the company had a lower net income in the recent quarter than it did in the previous quarter. While analysts expected Ginkgo Bioworks Holdings Inc. to report -$0.3 quarterly earnings, the actual figure was -$0.41 per share, beating the consensus estimate by -36.70%. During the quarter, the company generated -$643.51 million in EBITDA. The liabilities of Ginkgo Bioworks Holdings Inc. were 430.96 million at the end of its most recent quarter ended September 29, and its total debt was $59.84 million. The value of shareholders’ equity is $1.74 billion.
This quick technical analysis looks at Ginkgo Bioworks Holdings Inc.’s (DNA) price momentum. With a historical volatility rate of 88.72%, the RSI 9-day stood at 30.33% on 23 November.
With respect to its five-day moving average, the current Ginkgo Bioworks Holdings Inc. price is down by -14.66% percent or -$0.3400. At present, DNA shares trade -28.78% below its 20-day simple moving average and -26.67% percent below its 100-day simple moving average. However, the stock is currently trading approximately -35.50% below its SMA50 and -63.33% below its SMA200.
Stochastic coefficient K was 7.76% and Stochastic coefficient D was 13.57%, while ATR was 0.2310. Given the Stochastic reading of 4.00% for the 14-day period, the RSI (14) reading has been calculated as 34.89%. As of today, the MACD Oscillator reading stands at -0.3022, while the 14-day reading stands at -0.3552.